🇺🇸 FDA
Patent

US 11692010

Compounds that bind to human immunodeficiency virus rev response element

granted A61KA61K38/00A61K38/17

Quick answer

US patent 11692010 (Compounds that bind to human immunodeficiency virus rev response element) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/17, A61K45/06, A61K47/64